We have revised our Privacy Policy. By continuing to use our site, you accept our Privacy Policy and Terms of Service
Atypical HUS, in contrast, is a rare but devastating disease that can affect individuals of any age, from infancy to adulthood. Its name, "atypical," belies its clinical gravity. Unlike typical HUS, aHUS is not preceded by STEC infection. Instead, it is a primary disease of uncontrolled complement activation. In the majority of cases, aHUS is caused by inherited genetic mutations in complement regulatory proteins (e.g., factor H, factor I, MCP) or in activating proteins (e.g., factor B, C3). These mutations lead to a state of chronic, unchecked activation of the alternative complement pathway, resulting in persistent attack on the endothelium.
Hemolytic uremic syndrome (HUS) is a clinical triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. While this definition is clear, the syndrome is not a single disease but rather a spectrum of conditions with vastly different etiologies, treatments, and prognoses. The critical distinction lies between typical HUS, also known as Shiga toxin-producing E. coli HUS (STEC-HUS), and atypical HUS (aHUS). Although they share a common final pathway of endothelial damage and microvascular thrombosis, their underlying mechanisms, clinical triggers, and long-term outcomes diverge so significantly that they are best understood as two distinct disorders: one an acute, often self-limited infection, the other a chronic, life-threatening genetic disease of complement dysregulation. typical vs atypical hemolytic uremic syndrome
Typical HUS is primarily a disease of childhood, most frequently occurring after an episode of bloody diarrhea caused by specific strains of E. coli , most notably O157:H7. The pathogenesis begins in the gut, where the bacterium releases Shiga toxin. This toxin enters the bloodstream and targets vascular endothelial cells, particularly those in the kidneys and brain. Shiga toxin directly damages these cells, triggering a local inflammatory response and exposing the underlying basement membrane. This leads to platelet adhesion, aggregation, and the formation of microthrombi in the small blood vessels of the renal glomeruli. Atypical HUS, in contrast, is a rare but